The Chongqing intracerebral hemorrhage study is a multi-center, prospective, observational study led by professor Qi Li from Chongqing Medical University. Professor Peng Xie will be the senior consultant for the study. The Chongqing intracerebral hemorrhage study will focus on the epidemiology, natural history, pathogenesis, laboratory, radiological aspects, clinical outcomes and the effects of treatment in patients with intracerebral hemorrhage. The clinical, laboratory, imaging, genetic and outcome data of patients diagnosed with acute intracerebral hemorrhage will be prospectively collected. The prognosis of patients with intracerebral hemorrhage will be assessed by using several outcome measure scales at different time points.
The Chongqing intracerebral hemorrhage study will try to address several key issues in ICH. The baseline clinical data including demographic, disease severity scores, prior drug history and relevant medical history, premorbid mRS scores will be prospectively recorded. The admission and follow-up imaging data of all registered patients will be saved as Dicom format for future use and review. The functional outcomes will be assessed and recorded by experienced neurologists.
Study Type
OBSERVATIONAL
Enrollment
1,000
The First Affiliated Hospital of Chongqing Medical University
Chongqing, China
RECRUITINGhematoma volume growth at 24 hours
To assess early hematoma volume growth at 24 hours
Time frame: 24 hours
functional outcome at 3 months assessed by modified Ranking Scale
assess functional outcome at 3months using mRS
Time frame: 3 months
early neurological deterioration assessed by NIHSS score at 24 hours
To assess early neurological deterioration using NIHSS score at 24 hours
Time frame: 24 hours
early neurological deterioration assessed by NIHSS at 48 hours
To assess early neurological deterioration using NIHSS score at 48 hours
Time frame: 48 hours
early neurological deterioration assessed by NIHSS score
To assess early neurological deterioration using NIHSS score at 72 hours
Time frame: 72hours
perihematoma edema volume measurement at 24 hours
to measure the perihematoma edema volume at 24 hours
Time frame: 24 hours
perihematoma edema volume measurement at 72 hours
to measure the perihematoma edema volume at 72 hours
Time frame: 72 hours
intraventricular hemorrhage growth
to assess the presence of IVH at 24 hours
Time frame: 24 hours
major thromboembolic events
to assess the thromboembolic events 2 weeks after admission
Time frame: 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.